Inj docetaxel (hospira) 1 mg
Products billed under this code include Docetaxel.
Payment limit per 1 MG, by effective quarter, 3Q26 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J9232
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Docetaxel | Pfizer Inc | 00409-0016-01 | 160 | $82.08 |
| Docetaxel | Pfizer Inc | 00409-0201-02 | 20 | $10.26 |
| Docetaxel | Pfizer Inc | 00409-0201-10 | 80 | $41.04 |
| Docetaxel | Pfizer Inc | 00409-0201-20 | 160 | $82.08 |
| Docetaxel | Pfizer Inc | 00409-0365-01 | 160 | $82.08 |
| Docetaxel | Pfizer Inc | 00409-0366-01 | 20 | $10.26 |
| Docetaxel | Pfizer Inc | 00409-0367-01 | 80 | $41.04 |
| Docetaxel | Pfizer Inc | 00409-0368-01 | 160 | $82.08 |
| Docetaxel | Pfizer Inc | 00409-1732-01 | 160 | $82.08 |
| Docetaxel | Pfizer Inc | 00409-2026-01 | 20 | $10.26 |
Show all 31 products
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Docetaxel | Pfizer Inc | 00409-4235-01 | 20 | $10.26 |
| Docetaxel | Pfizer Inc | 00409-5068-01 | 80 | $41.04 |
| Docetaxel | Pfizer Inc | 00409-7870-01 | 80 | $41.04 |
| Docetaxel | Sagent Pharmaceuticals | 25021-0254-08 | 80 | $41.04 |
| Docetaxel | Sagent Pharmaceuticals | 25021-0254-16 | 160 | $82.08 |
| Docetaxel | Baxter Healthcare Corporation | 43066-0001-01 | 20 | $10.26 |
| Docetaxel | Baxter Healthcare Corporation | 43066-0006-01 | 80 | $41.04 |
| Docetaxel | Baxter Healthcare Corporation | 43066-0010-01 | 160 | $82.08 |
| Docetaxel | Baxter Healthcare Corporation | 43066-0044-02 | 20 | $10.26 |
| Docetaxel | Alembic Pharmaceuticals Inc. | 62332-0678-02 | 20 | $10.26 |
| Docetaxel | Alembic Pharmaceuticals Inc. | 62332-0678-08 | 80 | $41.04 |
| Docetaxel | Alembic Pharmaceuticals Inc. | 62332-0678-16 | 160 | $82.08 |
| Docetaxel | Sandoz Inc. | 66758-0050-01 | 20 | $10.26 |
| Docetaxel | Sandoz Inc. | 66758-0050-02 | 80 | $41.04 |
| Docetaxel | Sandoz Inc. | 66758-0050-03 | 160 | $82.08 |
| Docetaxel | Mylan Institutional LLC | 67457-0531-02 | 20 | $10.26 |
| Docetaxel | Mylan Institutional LLC | 67457-0532-08 | 80 | $41.04 |
| Docetaxel | Mylan Institutional LLC | 67457-0533-16 | 160 | $82.08 |
| Docetaxel | Meitheal Pharmaceuticals Inc. | 71288-0144-08 | 80 | $41.04 |
| Docetaxel | Meitheal Pharmaceuticals Inc. | 71288-0144-16 | 160 | $82.08 |
| Docetaxel | Mylan Institutional LLC | 72078-0040-08 | 80 | $41.04 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.513 | +$0.001 | 1 MG | Inj docetaxel (hospira) 1 mg | v1, posted September 17, 2026 |
| 3Q26 | $0.512 | – | 1 MG | Inj docetaxel (hospira) 1 mg | v1, posted September 15, 2026 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026